Fexofenadine Hydrochloride Tablets — Class II drug recall D-0907-2023
Terminated recall by L. Perrigo Company, reported 2023-07-19, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0907-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | L. Perrigo Company, Allegan, MI, United States |
| Recall initiated | 2023-02-09 |
| Classified | 2023-07-11 |
| Reported by FDA | 2023-07-19 |
| Terminated | 2023-09-11 |
| Distributed | Nationwide (US) |
| Quantity | 15,504 cartons |
| Reason classes | specification failure |
| NDC | 45802-0847, 45802-0847-78 |
| Lot numbers | 12/23, 2DR0351 |
Product
Fexofenadine Hydrochloride Tablets, 180 mg, 100-count cartons, Distributed by: Perrigo, Allegan, MI 49010. NDC 45802-847-78
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0907-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.